Home › Funds › TCG Crossover Management, LLC › JANX

TCG Crossover Management, LLC position in JANX

JANUX THERAPEUTICS INC · Health Care

TCG Crossover Management, LLC reported holding 1,789,617 shares of JANX (JANUX THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$27.5M, representing 0.66% of its reported portfolio and ranking #35 among its reported holdings. TCG Crossover Management, LLC has disclosed JANX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.79M sh
Reported value held$27.49M
Portfolio Weight0.66%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TCG Crossover Management, LLC's JANX position evolved

TCG Crossover Management, LLC first disclosed a stake in JANX in Q4 2025 at 1,789,617 shares (US$24.7M). The position peaked in Q2 2026 at 1,789,617 shares, worth US$27.5M. Across 3 filings, TCG Crossover Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,789,617 shares valued at US$27.5M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.79M $24.70M New
Q1 2026 1.79M $24.88M Hold
Q2 2026 1.79M $27.49M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JANX and 13F data

JANX (JANUX THERAPEUTICS INC) is a Health Care company. 27 other funds we track also report a position in JANX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$171.9M), Prosight Management, LP (US$58.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JANX

All JANX fund holders →

FAQ

How long has TCG Crossover Management, LLC held JANX?

TCG Crossover Management, LLC has disclosed JANX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is TCG Crossover Management, LLC's current position in JANX?

As of Q2 2026, TCG Crossover Management, LLC holds 1.79M shares of JANX (JANUX THERAPEUTICS INC), valued at $27.49M, representing 0.66% of its reported portfolio and ranking #35.

Has TCG Crossover Management, LLC been buying or selling JANX?

In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC held unchanged its position in JANX. The position peaked in Q2 2026 at 1.79M shares.

Which other funds hold JANX?

Other major institutional holders of JANX include RA CAPITAL MANAGEMENT, L.P., Prosight Management, LP, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.